Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (not Scisparc Ltd.) covers the month of September 2017. The registrant is a foreign private issuer based in Tel-Aviv, Israel, filing under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notice of a corporate event rather than a financial report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing.
Guidance, Outlook, and Corporate Events
The primary purpose of this filing is to announce the 2017 Annual General Meeting of Shareholders. Key details include:
- Date: October 25, 2017
- Time: 8:00 a.m. Eastern Standard Time / 3:00 p.m. Israel time
- Location: 4 Ariel Sharon Street, HaShahar Tower, 16th Floor, Tel-Aviv, Israel
- Attachments: Notice of Annual General Meeting, Proxy Statement, and Proxy Card are included as Exhibits 1 and 2.
Investor Verification Checklist
- Verify the correct registrant name is Therapix Biosciences Ltd., not Scisparc Ltd.
- Confirm the date and location of the Annual General Meeting for shareholder participation.
- Review the attached Proxy Statement (Exhibit 2) for specific agenda items and voting proposals.
- Note that no financial performance data is contained in this specific filing.